| Dr Robert N Moses, MD | |
|
8074 Mcintyre Square Dr., Pittsburgh, PA 15237 | |
| (207) 423-6106 | |
| Not Available |
| Full Name | Dr Robert N Moses |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 17 Years |
| Location | 8074 Mcintyre Square Dr., Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316146384 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 018910 (Maine) | Secondary |
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | MD447016 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Three Rivers Hospice | Monroeville, PA | Hospice |
| Butler Memorial Hospital | Butler, PA | Hospital |
| Uniontown Hospital | Uniontown, PA | Hospital |
| Quality Life Services - Chicora | Chicora, PA | Nursing home |
| Quality Life Services - New Castle | New castle, PA | Nursing home |
| Quality Life Services - Markleysburg | Markleysburg, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Quality Medical Associates Pc | 1951633049 | 2 |
News Archive
A survey called "Impact of Drug Shortages on U.S. Health Systems" released this Tuesday showed that a vast majority of U.S. hospitals have restricted the use of life-saving chemotherapy drugs and other critical-care medications in the past six months to cope with unprecedented shortages.
Stiefel, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong.
Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Reuters examines Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine's recent comments on the sidelines of the 9th International Conference on AIDS in Asia and the Pacific (ICAAP), that some emerging nations should consider becoming donor nations.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
› Verified 4 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
A survey called "Impact of Drug Shortages on U.S. Health Systems" released this Tuesday showed that a vast majority of U.S. hospitals have restricted the use of life-saving chemotherapy drugs and other critical-care medications in the past six months to cope with unprecedented shortages.
Stiefel, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong.
Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Reuters examines Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine's recent comments on the sidelines of the 9th International Conference on AIDS in Asia and the Pacific (ICAAP), that some emerging nations should consider becoming donor nations.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
› Verified 4 days ago
| Entity Name | North Pittsburgh Pain Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255660767 PECOS PAC ID: 5496890279 Enrollment ID: O20100304000313 |
News Archive
A survey called "Impact of Drug Shortages on U.S. Health Systems" released this Tuesday showed that a vast majority of U.S. hospitals have restricted the use of life-saving chemotherapy drugs and other critical-care medications in the past six months to cope with unprecedented shortages.
Stiefel, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong.
Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Reuters examines Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine's recent comments on the sidelines of the 9th International Conference on AIDS in Asia and the Pacific (ICAAP), that some emerging nations should consider becoming donor nations.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
› Verified 4 days ago
| Entity Name | Integrated Rehab Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528379195 PECOS PAC ID: 7810184892 Enrollment ID: O20120213000671 |
News Archive
A survey called "Impact of Drug Shortages on U.S. Health Systems" released this Tuesday showed that a vast majority of U.S. hospitals have restricted the use of life-saving chemotherapy drugs and other critical-care medications in the past six months to cope with unprecedented shortages.
Stiefel, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong.
Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Reuters examines Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine's recent comments on the sidelines of the 9th International Conference on AIDS in Asia and the Pacific (ICAAP), that some emerging nations should consider becoming donor nations.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
› Verified 4 days ago
| Entity Name | Dlp Conemaugh Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932515905 PECOS PAC ID: 7315166949 Enrollment ID: O20140915002522 |
News Archive
A survey called "Impact of Drug Shortages on U.S. Health Systems" released this Tuesday showed that a vast majority of U.S. hospitals have restricted the use of life-saving chemotherapy drugs and other critical-care medications in the past six months to cope with unprecedented shortages.
Stiefel, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong.
Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Reuters examines Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine's recent comments on the sidelines of the 9th International Conference on AIDS in Asia and the Pacific (ICAAP), that some emerging nations should consider becoming donor nations.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
› Verified 4 days ago
| Entity Name | National Health Rehabilitation Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780080218 PECOS PAC ID: 4284952615 Enrollment ID: O20170330000520 |
News Archive
A survey called "Impact of Drug Shortages on U.S. Health Systems" released this Tuesday showed that a vast majority of U.S. hospitals have restricted the use of life-saving chemotherapy drugs and other critical-care medications in the past six months to cope with unprecedented shortages.
Stiefel, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong.
Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Reuters examines Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine's recent comments on the sidelines of the 9th International Conference on AIDS in Asia and the Pacific (ICAAP), that some emerging nations should consider becoming donor nations.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
› Verified 4 days ago
| Entity Name | Choice Restorative Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578076774 PECOS PAC ID: 9739437336 Enrollment ID: O20180730001337 |
News Archive
A survey called "Impact of Drug Shortages on U.S. Health Systems" released this Tuesday showed that a vast majority of U.S. hospitals have restricted the use of life-saving chemotherapy drugs and other critical-care medications in the past six months to cope with unprecedented shortages.
Stiefel, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong.
Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Reuters examines Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine's recent comments on the sidelines of the 9th International Conference on AIDS in Asia and the Pacific (ICAAP), that some emerging nations should consider becoming donor nations.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
› Verified 4 days ago
| Entity Name | Pcma Physical Medicine & Rehabilitation Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639652738 PECOS PAC ID: 7719222132 Enrollment ID: O20181212003563 |
News Archive
A survey called "Impact of Drug Shortages on U.S. Health Systems" released this Tuesday showed that a vast majority of U.S. hospitals have restricted the use of life-saving chemotherapy drugs and other critical-care medications in the past six months to cope with unprecedented shortages.
Stiefel, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong.
Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Reuters examines Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine's recent comments on the sidelines of the 9th International Conference on AIDS in Asia and the Pacific (ICAAP), that some emerging nations should consider becoming donor nations.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
› Verified 4 days ago
| Entity Name | Quality Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407316276 PECOS PAC ID: 1951633049 Enrollment ID: O20191022002354 |
News Archive
A survey called "Impact of Drug Shortages on U.S. Health Systems" released this Tuesday showed that a vast majority of U.S. hospitals have restricted the use of life-saving chemotherapy drugs and other critical-care medications in the past six months to cope with unprecedented shortages.
Stiefel, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong.
Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Reuters examines Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine's recent comments on the sidelines of the 9th International Conference on AIDS in Asia and the Pacific (ICAAP), that some emerging nations should consider becoming donor nations.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert N Moses, MD 146 Woodbury Dr, Sarver, PA 16055-9428 Ph: (207) 423-6106 | Dr Robert N Moses, MD 8074 Mcintyre Square Dr., Pittsburgh, PA 15237 Ph: (207) 423-6106 |
News Archive
A survey called "Impact of Drug Shortages on U.S. Health Systems" released this Tuesday showed that a vast majority of U.S. hospitals have restricted the use of life-saving chemotherapy drugs and other critical-care medications in the past six months to cope with unprecedented shortages.
Stiefel, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong.
Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Reuters examines Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine's recent comments on the sidelines of the 9th International Conference on AIDS in Asia and the Pacific (ICAAP), that some emerging nations should consider becoming donor nations.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
› Verified 4 days ago
Dr. Joseph Chak Ka Kwok, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3471 5th Ave, Kaufman Building Suite 201, Pittsburgh, PA 15213 Phone: 412-648-6138 Fax: 412-692-4354 | |
Brian Higdon, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3471 5th Ave, Kaufmann Medical Building Suite 201, Pittsburgh, PA 15213 Phone: 309-972-7688 | |
James Craig, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9104 Babcock Blvd, Suite 2120, Pittsburgh, PA 15237 Phone: 412-367-0600 | |
Dr. Mark Spencer Wilcox, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1000 Bower Hill Rd, Pittsburgh, PA 15243 Phone: 412-831-2300 | |
Dr. Ryan Paul Nussbaum, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1400 Locust St Ste 11516, Pittsburgh, PA 15219 Phone: 412-232-8949 | |
Judith Esman, Physical Medicine & Rehabilitation Medicare: May Accept Medicare Assignments Practice Location: 9104 Babcock Blvd, Suite 2120, Pittsburgh, PA 15237 Phone: 412-367-0600 | |
Amy Wagner, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3471 5th Ave, Suite 1103, Pittsburgh, PA 15213 Phone: 412-648-6848 |